FDA Inspection
Kindos Pharmaceuticals Co., Ltd.Kindos Pharmaceuticals Co., Ltd. – FDA Inspection, Apr 1, 2017
Record Details
This FDA Inspection record concerns Kindos Pharmaceuticals Co., Ltd., with an inspection on April 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8c645e62-a8ca-4341-9397-64df42393ed5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009271
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Kindos Pharmaceuticals Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 24, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kindos Pharmaceuticals Co., Ltd.
- FDA Inspection 1244269 - 2024-07-19
- FDA Inspection 1101348 - 2019-07-30
- FDA Inspection 978257 - 2016-06-02
- FDA Inspection 941452 - 2015-04-10
- FDA Inspection 807892 - 2012-07-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.